Medical device recalls Moderate risk

Roche Molecular Systems, Inc. recalls cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number 07341920190

Recall date
November 16, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0828-2022
FDA classification
Class II
Brand / firm
Roche Molecular Systems, Inc.
Sold / distributed
Worldwide distribution - US Nationwide distribution in the states of CO, IL, IN, KY, MI, NC, and TX. The countries of Cyprus, Spain, and Hong Kong.

Why it was recalled

Roche has identified a small number of cobas Liat analyzer units that have consistently high noise levels (background signal) originating from the amber detector (used for Influenza B detection). This noise increases the probability of false positive Influenza B results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number 07341920190

Get recall alerts

Free email alert whenever Roche Molecular Systems, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Roche Molecular Systems, Inc.